Keynote Address
Leukemia (2003) 17, 496–498. doi:10.1038/sj.leu.2402864
Induction and postremission therapy: new agents
This paper is part of a series of keynote addresses to be published in Leukemia. They were presented at the Acute Leukemia Forum, San Fransisco, 19 April 2002. Supported by an unrestricted educational grant from Immunex.
R M Stone1
1Adult Leukemia Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Correspondence: RM Stone, Harvard Medical School, Adult Leukemia Program, Dana-Farber Cancer Institute, 44 Binney Street, Room D-840, Boston, MA 02115-6084, USA. Fax: 1 617 632 2933
Received 19 September 2002; Accepted 15 November 2002.
